Cargando…
Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal Angiomyolipoma From Chromophobe Renal Cell Carcinoma
OBJECTIVE: To evaluate the value of 2-dimensional (2D) and 3-dimensional (3D) computed tomography texture analysis (CTTA) models in distinguishing fat-poor angiomyolipoma (fpAML) from chromophobe renal cell carcinoma (chRCC). METHODS: We retrospectively enrolled 32 fpAMLs and 24 chRCCs. Texture feat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801892/ https://www.ncbi.nlm.nih.gov/pubmed/31625454 http://dx.doi.org/10.1177/1536012119883161 |
_version_ | 1783460684990775296 |
---|---|
author | Yang, Guangjie Gong, Aidi Nie, Pei Yan, Lei Miao, Wenjie Zhao, Yujun Wu, Jie Cui, Jingjing Jia, Yan Wang, Zhenguang |
author_facet | Yang, Guangjie Gong, Aidi Nie, Pei Yan, Lei Miao, Wenjie Zhao, Yujun Wu, Jie Cui, Jingjing Jia, Yan Wang, Zhenguang |
author_sort | Yang, Guangjie |
collection | PubMed |
description | OBJECTIVE: To evaluate the value of 2-dimensional (2D) and 3-dimensional (3D) computed tomography texture analysis (CTTA) models in distinguishing fat-poor angiomyolipoma (fpAML) from chromophobe renal cell carcinoma (chRCC). METHODS: We retrospectively enrolled 32 fpAMLs and 24 chRCCs. Texture features were extracted from 2D and 3D regions of interest in triphasic CT images. The 2D and 3D CTTA models were constructed with the least absolute shrinkage and selection operator algorithm and texture scores were calculated. The diagnostic performance of the 2D and 3D CTTA models was evaluated with respect to calibration, discrimination, and clinical usefulness. RESULTS: Of the 177 and 183 texture features extracted from 2D and 3D regions of interest, respectively, 5 2D features and 8 3D features were selected to build 2D and 3D CTTA models. The 2D CTTA model (area under the curve [AUC], 0.811; 95% confidence interval [CI], 0.695-0.927) and the 3D CTTA model (AUC, 0.915; 95% CI, 0.838-0.993) showed good discrimination and calibration (P > .05). There was no significant difference in AUC between the 2 models (P = .093). Decision curve analysis showed the 3D model outperformed the 2D model in terms of clinical usefulness. CONCLUSIONS: The CTTA models based on contrast-enhanced CT images had a high value in differentiating fpAML from chRCC. |
format | Online Article Text |
id | pubmed-6801892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-68018922019-10-30 Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal Angiomyolipoma From Chromophobe Renal Cell Carcinoma Yang, Guangjie Gong, Aidi Nie, Pei Yan, Lei Miao, Wenjie Zhao, Yujun Wu, Jie Cui, Jingjing Jia, Yan Wang, Zhenguang Mol Imaging Artificial Intelligence in Molecular Imaging Clinics OBJECTIVE: To evaluate the value of 2-dimensional (2D) and 3-dimensional (3D) computed tomography texture analysis (CTTA) models in distinguishing fat-poor angiomyolipoma (fpAML) from chromophobe renal cell carcinoma (chRCC). METHODS: We retrospectively enrolled 32 fpAMLs and 24 chRCCs. Texture features were extracted from 2D and 3D regions of interest in triphasic CT images. The 2D and 3D CTTA models were constructed with the least absolute shrinkage and selection operator algorithm and texture scores were calculated. The diagnostic performance of the 2D and 3D CTTA models was evaluated with respect to calibration, discrimination, and clinical usefulness. RESULTS: Of the 177 and 183 texture features extracted from 2D and 3D regions of interest, respectively, 5 2D features and 8 3D features were selected to build 2D and 3D CTTA models. The 2D CTTA model (area under the curve [AUC], 0.811; 95% confidence interval [CI], 0.695-0.927) and the 3D CTTA model (AUC, 0.915; 95% CI, 0.838-0.993) showed good discrimination and calibration (P > .05). There was no significant difference in AUC between the 2 models (P = .093). Decision curve analysis showed the 3D model outperformed the 2D model in terms of clinical usefulness. CONCLUSIONS: The CTTA models based on contrast-enhanced CT images had a high value in differentiating fpAML from chRCC. SAGE Publications 2019-10-18 /pmc/articles/PMC6801892/ /pubmed/31625454 http://dx.doi.org/10.1177/1536012119883161 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Artificial Intelligence in Molecular Imaging Clinics Yang, Guangjie Gong, Aidi Nie, Pei Yan, Lei Miao, Wenjie Zhao, Yujun Wu, Jie Cui, Jingjing Jia, Yan Wang, Zhenguang Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal Angiomyolipoma From Chromophobe Renal Cell Carcinoma |
title | Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal
Angiomyolipoma From Chromophobe Renal Cell Carcinoma |
title_full | Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal
Angiomyolipoma From Chromophobe Renal Cell Carcinoma |
title_fullStr | Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal
Angiomyolipoma From Chromophobe Renal Cell Carcinoma |
title_full_unstemmed | Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal
Angiomyolipoma From Chromophobe Renal Cell Carcinoma |
title_short | Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal
Angiomyolipoma From Chromophobe Renal Cell Carcinoma |
title_sort | contrast-enhanced ct texture analysis for distinguishing fat-poor renal
angiomyolipoma from chromophobe renal cell carcinoma |
topic | Artificial Intelligence in Molecular Imaging Clinics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801892/ https://www.ncbi.nlm.nih.gov/pubmed/31625454 http://dx.doi.org/10.1177/1536012119883161 |
work_keys_str_mv | AT yangguangjie contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT gongaidi contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT niepei contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT yanlei contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT miaowenjie contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT zhaoyujun contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT wujie contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT cuijingjing contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT jiayan contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma AT wangzhenguang contrastenhancedcttextureanalysisfordistinguishingfatpoorrenalangiomyolipomafromchromophoberenalcellcarcinoma |